Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 7
1977 7
1978 5
1979 6
1980 3
1981 4
1982 7
1983 6
1984 9
1985 11
1986 14
1987 8
1988 6
1989 9
1990 10
1991 11
1992 11
1993 10
1994 9
1995 12
1996 13
1997 6
1998 16
1999 12
2000 3
2001 11
2002 8
2003 16
2004 11
2005 6
2006 7
2007 11
2008 11
2009 11
2010 10
2011 12
2012 17
2013 14
2014 13
2015 8
2016 8
2017 10
2018 13
2019 12
2020 7
2021 14
2022 16
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

444 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Amikacin response"
Page 1
Treatment of Mycobacterium abscessus Pulmonary Disease.
Griffith DE, Daley CL. Griffith DE, et al. Chest. 2022 Jan;161(1):64-75. doi: 10.1016/j.chest.2021.07.035. Epub 2021 Jul 24. Chest. 2022. PMID: 34314673 Review.
After the macrolides, amikacin is regarded as the next most important drug for M abscessus treatment, although data validating that assertion are lacking. The considerations for preventing acquired macrolide resistance also apply to amikacin. Recent guidelines sugge …
After the macrolides, amikacin is regarded as the next most important drug for M abscessus treatment, although data validating that a …
Aminoglycoside-induced ototoxicity.
Selimoglu E. Selimoglu E. Curr Pharm Des. 2007;13(1):119-26. doi: 10.2174/138161207779313731. Curr Pharm Des. 2007. PMID: 17266591 Review.
Among them, streptomycin and gentamicin are primarily vestibulotoxic, whereas amikacin, neomycin, dihydrosterptomycin, and kanamicin are primarily cochleotoxic. ...
Among them, streptomycin and gentamicin are primarily vestibulotoxic, whereas amikacin, neomycin, dihydrosterptomycin, and kanamicin …
How do I manage nocardiosis?
Margalit I, Lebeaux D, Tishler O, Goldberg E, Bishara J, Yahav D, Coussement J. Margalit I, et al. Clin Microbiol Infect. 2021 Apr;27(4):550-558. doi: 10.1016/j.cmi.2020.12.019. Epub 2021 Jan 5. Clin Microbiol Infect. 2021. PMID: 33418019 Free article.
When combination therapy is required, the repertoire of companion drugs includes third-generation cephalosporins, amikacin and imipenem. Therapeutic modifications should take into account clinical response to initial therapy and AST results. ...
When combination therapy is required, the repertoire of companion drugs includes third-generation cephalosporins, amikacin and imipen …
Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.
Jenkins A, Thomson AH, Brown NM, Semple Y, Sluman C, MacGowan A, Lovering AM, Wiffen PJ; (BSAC Working Party on Therapeutic Drug Monitoring). Jenkins A, et al. J Antimicrob Chemother. 2016 Oct;71(10):2754-9. doi: 10.1093/jac/dkw250. Epub 2016 Jul 11. J Antimicrob Chemother. 2016. PMID: 27494904 Free article. Review.
METHODS: A literature review was conducted in Medline, EMBASE and the Cochrane Central Register of Controlled Trials. Full journal articles reporting randomized controlled trials, controlled clinical trials, interrupted time series trials, and controlled before and …
METHODS: A literature review was conducted in Medline, EMBASE and the Cochrane Central Register of Controlled Trials. Full journal articles …
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Perry CM, Markham A. Perry CM, et al. Drugs. 1999 May;57(5):805-43. doi: 10.2165/00003495-199957050-00017. Drugs. 1999. PMID: 10353303 Review.
In patients with intra-abdominal infections, clinical and bacteriological response rates were significantly higher with piperacillin/tazobactam than with imipenem/cilastatin (administered at a dosage lower than is recommended in countries outside Scandinavia). Piper …
In patients with intra-abdominal infections, clinical and bacteriological response rates were significantly higher with pipera …
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, Lange C, Laniado-Laborín R, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D; Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017. Lan Z, et al. Lancet Respir Med. 2020 Apr;8(4):383-394. doi: 10.1016/S2213-2600(20)30047-3. Epub 2020 Mar 17. Lancet Respir Med. 2020. PMID: 32192585 Free PMC article.
We also considered for this analysis studies contributing patient-level data in response to a public call made by WHO in 2018. Meta-analysis for proportions and arm-based network meta-analysis were done to estimate the incidence of adverse events for each tuberculosis drug …
We also considered for this analysis studies contributing patient-level data in response to a public call made by WHO in 2018. Meta-a …
Pyopneumothorax of unusual aetiology.
Leo S, Narasimhan M, Imran Khan M. Leo S, et al. Trop Doct. 2022 Jul;52(3):456-458. doi: 10.1177/00494755221089461. Epub 2022 Mar 23. Trop Doct. 2022. PMID: 35321613
A 50-year old diabetic male presented with cough, breathlessness, fever, and chest pain. Clinical and radiological evaluation revealed a right-sided pyopneumothorax. ...Pleural fluid cultures grew Enterococcus fecium as a sole organism. Our patient was treated with vancomy …
A 50-year old diabetic male presented with cough, breathlessness, fever, and chest pain. Clinical and radiological evaluation reveale …
Endophthalmitis.
Elder MJ, Morlet N; EPSWA. Endophthalmitis Population Study of Western Australia. Elder MJ, et al. Clin Exp Ophthalmol. 2002 Dec;30(6):394-8. doi: 10.1046/j.1442-9071.2002.00567.x. Clin Exp Ophthalmol. 2002. PMID: 12427228
Australia and New Zealand continue to be at the forefront of endophthalmitis research. In this Clinical Controversy, an ophthalmologist from each country presents different approaches to the management of a 72-year-old patient with routine endophthalmitis following catarac …
Australia and New Zealand continue to be at the forefront of endophthalmitis research. In this Clinical Controversy, an ophthalmologi …
Amikacin Therapy in Japanese Pediatric Patients: Narrative Review.
Kato H, Hamada Y. Kato H, et al. Int J Environ Res Public Health. 2022 Feb 10;19(4):1972. doi: 10.3390/ijerph19041972. Int J Environ Res Public Health. 2022. PMID: 35206156 Free PMC article. Review.
Therefore, whether current evidence of how developmental change affects PK and exposure-response relationships applies to Japanese pediatric patients remains unclear. This narrative review focuses on amikacin therapy in Japanese pediatric patients and shows the rela …
Therefore, whether current evidence of how developmental change affects PK and exposure-response relationships applies to Japanese pe …
An overview of amikacin.
Ristuccia AM, Cunha BA. Ristuccia AM, et al. Ther Drug Monit. 1985;7(1):12-25. doi: 10.1097/00007691-198503000-00003. Ther Drug Monit. 1985. PMID: 3887667 Review.
High response rates have been reported with the use of amikacin combined with beta-lactam antibiotics in immunocompromised or granulocytopenic patients. ...Amikacin achieves high and predictable serum concentrations and has a favorable therapeutic index. ...
High response rates have been reported with the use of amikacin combined with beta-lactam antibiotics in immunocompromised or …
444 results